Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.

Saved in:
Bibliographic Details
Title: Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.
Authors: Zengin, Zeynep B.1 (AUTHOR), Chehrazi-Raffle, Alex1 (AUTHOR), Salgia, Nicholas J.1 (AUTHOR), Muddasani, Ramya1 (AUTHOR), Ali, Sana2 (AUTHOR), Meza, Luis1 (AUTHOR), Pal, Sumanta K.1 (AUTHOR) spal@coh.org
Source: Urologic Oncology. Feb2022, Vol. 40 Issue 2, p25-36. 12p.
Database: Academic Search Ultimate
Description
ISSN:10781439
DOI:10.1016/j.urolonc.2021.10.003